Cohance Lifesciences Ltd.

NSE: SUVENPHAR | BSE: 543064

Expensive Underperformer

Download real time

1079.20 21.00 (1.98%)

80.47% Gain from 52W Low

1.2M NSE+BSE Volume

High volume today

NSE 16 May, 2025 3:31 PM (IST)

27,472.7

Market Cap

High in industry

0.5

Beta 1Year

Very Low volatility

Board Meeting

The next board meeting for Cohance Lifesciences Ltd. is on 28 May 2025 for the purpose of Audited Results See details

Cohance Lifesciences Ltd. Earnings/Conference Calls

Cohance Lifesciences Ltd. earnings concalls and investor presentations

VOTE: Is Suven Pharmaceuticals Ltd. worth buying?

22 Votes:

Buy 63.64%

Sell 13.64%

Hold 22.73%

RESEARCH REPORTS

Buy SEE REPORTS >

Buy SEE REPORTS >